Episode Details

Back to Episodes
Obutinib treatment for SLE phase IIb study achieves primary endpoint and is approved for

Obutinib treatment for SLE phase IIb study achieves primary endpoint and is approved for

Published 7 months, 1 week ago
Description
Smf5Yv7iSAZW7lGwgunC
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us